Head and Neck Cancer Trial, Recruiting (NCT05447169)

Head and Neck Cancer Trial, Recruiting NCT05447169 Sponsor: Sun Yat-sen University Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05447169 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who currently live in Southern China
People between the ages of 30 and 62 years old
People who are male
People who have at least one close blood relative (such as a parent, sibling, or child) who has been diagnosed with nasopharyngeal carcinoma (a type of throat cancer)
People who have no previous diagnosis of nasopharyngeal carcinoma
People who have a general health status rated as fairly active or better, meaning they are able to carry out daily activities with little to no restriction (confirm with trial site regarding the specific rating scale used)
People who are able to understand, sign, and date the study's consent forms

Who may not be able to join:

People who have previously been diagnosed with nasopharyngeal carcinoma
People who have serious heart, liver, or kidney disease
People who are currently taking steroid medications or medicines that suppress the immune system, or who have an active autoimmune condition (where the body's immune system attacks its own tissues)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ming-Yuan Chen, MD, PhD, Sun Yat-sen University

Phone: 86-20-8734-3361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05447169

Sponsor: Sun Yat-sen University

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 86-20-8734-3361

More information: https://clinicaltrials.gov/study/NCT05447169

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who currently live in Southern China
People between the ages of 30 and 62 years old
People who are male
People who have at least one close blood relative (such as a parent, sibling, or child) who has been diagnosed with nasopharyngeal carcinoma (a type of throat cancer)
People who have no previous diagnosis of nasopharyngeal carcinoma
People who have a general health status rated as fairly active or better, meaning they are able to carry out daily activities with little to no restriction (confirm with trial site regarding the specific rating scale used)
People who are able to understand, sign, and date the study's consent forms

Who may not be able to join:

People who have previously been diagnosed with nasopharyngeal carcinoma
People who have serious heart, liver, or kidney disease
People who are currently taking steroid medications or medicines that suppress the immune system, or who have an active autoimmune condition (where the body's immune system attacks its own tissues)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sun Yat-sen University

Registry

ClinicalTrials.gov

Start date

10 July 2022

Est. completion

1 July 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

positive predictive value; negative predictive value

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov